Need help placing an order? Call us Toll-Free: 1-888-668-2808.
Save 10% off on your first order with coupon code: FIRST
Satisfaction Guarantee: Every order will receive a 30-day guarantee of up to $1,000 of the purchase price, that you will receive the products you ordered.
What is Novolin GE NPH Vial?
It contains intermediate-acting insulin called Insulin Isophane or NPH.
Novolin GE NPH Vial appears to be a cloudy or milky suspension. It is an Over the Counter (OTC) medicine that has 100 units/mL solution for injection. The vials are made for use with Insulin syringes.
What is it used for?
Novolin GE NPH helps reduce blood glucose levels in adults or pediatric patients who have Type 1 or Type 2 Diabetes Mellitus. Novolin helps prevent blindness, nerve problems, kidney damage, heart attack, and stroke.
How does it work?
Novolin regulates glucose metabolism by stimulating peripheral glucose uptake and enhances amino acid synthesis. It can also inhibit lipolysis, proteolysis, and hepatic glucose synthesis. It has a maximum effect between 4-12 hours after injection and stops working after 24 hours.
How to take it?
Inspect if the Novolin Vial contains a cloudy or white solution. Remove the drug from the refrigerator and gently roll the pen between the palms 10 times in a horizontal manner until it reaches room temperature. Discard the vial immediately if the medicine appears grainy, has crystals, or is lumpy. The patient can take this medication 30 minutes before meals. Inject air into the vial then gently press the plunger. Turn the vial and syringe upside down then draw the right dose of Novolin into the syringe. Pull the needle out of the vial and make sure there is no air left inside the syringe. The patient may inject Novolin subcutaneously in the abdomen, upper arms, buttocks, or upper legs and change the administration site every after the dose to lessen the risk of developing skin problems in the injection site. Novolin may be used alone or mixed with fast-acting soluble insulin. Do not inject intravenously or intramuscularly. Do not rub the site of injection after administration
It will base on the patient’s metabolic needs, blood sugar monitoring, and glycemic control goal. Dose adjustments may be done with patients taking Novolin with other drugs or a Change in Insulin regimen.
Sweating, dizziness or light-headedness, hunger, fast heart rate, headache, slurred speech, blurred vision, and anxiety are the common symptoms of taking this medication.
Warnings, Precautions, and Contraindications
Never share Novolin GE NPH Vial with other patients even if the needle is changed. Thiazolidinediones or other Peroxisome Proliferator-Activated Receptor (PPAR)-gamma agonists in combination with Novolin can cause fluid retention and may progress to heart failure. Dose adjustments must be done for a patient taking this medication with ACE inhibitors, Antidiabetic agents, Angiotensin II receptor blockers, sulphonamide antibiotics, atypical antipsychotics, corticosteroids, sympathomimetic agents, alcohol, beta-blockers, pentamidine, and reserpine. Patients with Renal impairment and Hepatic impairment have an increased risk of having hypoglycemia and thus require frequent blood sugar monitoring.
Novolin may cause acute peripheral neuropathy, worsen diabetic retinopathy, Anaphylaxis due to hypersensitivity, Hypoglycemia, Hypokalemia, depression of the skin, enlargement or thickening of tissue, weight gain, sodium retention, edema because of poor metabolic control, Localized cutaneous amyloidosis.
Do not freeze or expose to direct heat as it will destroy the product. Keep Novolin NPH Vial inside the carton so it will stay clean. The sealed vial is stored in a refrigerator with a temperature ranging from 2-8°C The vial that is currently in use should not be stored in the refrigerator and be kept a room temperature. Unrefrigerated vials must be thrown away 28 days after first use.
Do not dispose of this drug in wastewater or recycle needles and syringes. Placed used needles in a puncture-resistant sharps container with a screw cap.
About the Author
Ida Edlweiss Gumpal is a licensed Pharmacist and medical writer. She took her internships at Mercury Drug Corporation, Inc., a Hospital internship at De Vera Medical Center, Inc., and a Manufacturing internship at Philmed Laboratories, Inc. She has plans on attending medical school with the goal of specializing in Neurosurgery or Cardiothoracic surgery.